Dopamine receptor antagonist

This page covers all Dopamine receptor antagonist drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting D2/D3 receptor, D2 receptor.

Targets

D2/D3 receptor · D2 receptor

Phase 2 pipeline (2)

• ACT-709478 for oral use · Idorsia Pharmaceuticals Ltd. · Psychiatry
  ACT-709478 is a selective dopamine receptor D2/D3 antagonist.
• AP09004 · Intec Pharma Ltd. · Neurology
  AP09004 is a drug that targets the dopamine receptor D2.